Evidence map›Paper›PMID 41031861›Full record

ArticleCurrent protocols2025

Use of a Dihydroxyacetone Derivative as Protecting Reagent to Phosphorylate Oligonucleotides.

Rémy Lartia

Abstract read
In one paragraph

Article in Current protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Rémy LartiaDépartement de Chimie Moléculaire, CNRS UMR 5250, Université Grenoble Alpes, Grenoble, France.ORCID https://orcid.org/0000-0002-0049-6726

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present here a new reagent enabling the supported synthesis of oligodeoxynucleotides (ODNs) and oligoribonucleotides (ORNs) containing a phosphate group at the 5'-terminal position after complete deprotection. This reagent, derived from a dihydroxyacetone core, contains a dimethoxytrityl (DMTr) group. The procedure for final deprotection is very similar to that routinely used in the synthesis of unmodified ODNs or ORNs. In particular, it preserves the advantages of the "trityl-on" method, namely facile purification by reverse-phase high-performance liquid chromatography (RP-HPLC), short treatment with an acetic acid solution in water, the possibility of on-resin monitoring by trityl cation assay, and the use of equipment commonly founded in chemical laboratories. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol: Phosphorylation of oligodeoxyribonucleotides (ODNs) Alternate Protocol: Phosphorylation of oligoribonucleotides (ORNs) Support Protocol: Preparation of phosphorylation reagent 1.

Indexed as

DihydroxyacetoneOligodeoxyribonucleotidesOligonucleotidesChromatography, High Pressure LiquidChromatography, Reverse-PhaseIndicators and ReagentsPhosphorylationDihydroxyacetoneIndicators and ReagentsOligodeoxyribonucleotidesOligonucleotidesphosphorylation reagentRNA‐compatible“trityl‐on” method

Identifiers

PMID41031861
PMCPMC12487592

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.